Senseonics Holdings, Inc.
Develops and commercializes long-term, implantable glucose monitoring systems.
SENS | US
Overview
Corporate Details
- ISIN(s):
- US81727U1051
- LEI:
- Country:
- United States of America
- Address:
- 20451 SENECA MEADOWS PARKWAY, 20876 GERMANTOWN
- Website:
- https://www.senseonics.com/
- Sector:
- Manufacturing
Description
Senseonics Holdings, Inc. is a medical technology company focused on the design, development, and commercialization of glucose monitoring products for people with diabetes. The company's primary offering is the Eversense® Continuous Glucose Monitoring (CGM) System, distinguished as the first and only long-term, implantable glucose sensor. The system consists of a sensor inserted subcutaneously, a removable smart transmitter worn over the sensor, and a mobile application for displaying real-time glucose data, trends, and alerts. The Eversense system is designed to provide continuous glucose monitoring for up to six months from a single sensor, aiming to reduce the frequency of sensor insertions compared to traditional CGM systems.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Senseonics Holdings, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Senseonics Holdings, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Senseonics Holdings, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
